Department of Clinical Immunology, Alexandrovska University Hospital, Medical University, Sofia, Bulgaria.
Leuk Res. 2011 Aug;35(8):1120-3. doi: 10.1016/j.leukres.2011.04.012. Epub 2011 May 12.
MPL exon 10 mutations were the second class of mutations shown to be associated with the pathogenesis of some Philadelphia chromosome - negative myeloproliferative neoplasms (MPNs). Recently, their identification gained wide recognition in the diagnostic work-up for suspected cases of JAK2 V617F negative MPNs. Various molecular approaches have been applied, yet universally accepted method is still lacking. We aimed at development and validation of a novel bead-based liquid assay using Locked nucleic acids (LNA)-modified oligonucleotide probes for multiplexed detection of the following MPL mutations: W515L/K/A/R. Testing on both artificial plasmid constructs and on clinical samples revealed that the method was comparable in terms of specificity to direct sequencing and had a much higher sensitivity of 1% mutant alleles. This method could be successfully implemented in the diagnostic work-up for MPNs. Furthermore, this system allows further multiplexing for single-tube identification of different mutations associated with MPNs.
MPL 外显子 10 突变是第二类与某些费城染色体阴性骨髓增殖性肿瘤(MPN)发病机制相关的突变。最近,它们在疑似 JAK2 V617F 阴性 MPN 患者的诊断中得到了广泛认可。已经应用了各种分子方法,但仍缺乏普遍接受的方法。我们旨在开发和验证一种新型基于珠子的液体分析,使用锁核酸(LNA)修饰的寡核苷酸探针,用于多重检测以下 MPL 突变:W515L/K/A/R。在人工质粒构建体和临床样本上的测试表明,该方法在特异性方面与直接测序相当,并且具有高得多的 1%突变等位基因灵敏度。该方法可成功应用于 MPN 的诊断。此外,该系统允许进一步在单个管中对与 MPN 相关的不同突变进行多重检测。